Elevated
by intention.
The brand that exists because formulation and market failed a specific woman.
No product existed at efficacious doses. So we built it.
Ayas Swain, at 30, faced rising LDL, elevated blood pressure, and an HbA1c trending in the wrong direction. The clinical literature offered clear answers: berberine for glucose and lipids, green tea extract for glycaemic and cardiovascular support, chromium for insulin sensitivity, resveratrol for vascular function, ginger for the gut-metabolic axis, B420® probiotic for metabolic and digestive support.
Six ingredients, each at doses that appeared in actual clinical trials. But no product combined them at efficacious doses at a price point that made sense. The evidence was there. The market was not.
Thussheeta Singh, a New Zealand-qualified pharmacist with over a decade in clinical practice, arrived at the same gap from the other side. The brand exists because formulation and market failed a specific woman, and the founders had the training and the frustration to build the thing that should have existed.
"No product existed that combined these ingredients at efficacious doses. So we built it."
Ayas Swain & Thussheeta Singh · Co-founders
The supplement aisle had a credibility problem.
Most supplement labels include headline ingredients. The names are credible: berberine, resveratrol, green tea extract. The doses are not. A clinical trial uses 1,500 mg of berberine daily to support glucose metabolism. A typical supplement includes 50 mg and calls it a berberine formula.
Proprietary blends make this worse. By listing ingredients without individual amounts, brands can include headline ingredients at any dose, even negligible ones, without disclosure. It is legal. It is common. And it is the reason most supplements in this category do not perform the way the marketing implies.
An ingredient listed at a quantity far below the dose used in clinical research. The label appears comprehensive. The formulation is not.
Every ingredient at the dose used in supporting clinical trials, or not included at all. The only standard Maison Belasi formulates to.
Built by the people who felt the gap.
Ayas Swain brings a background in brand strategy and commercial development. The personal experience of navigating metabolic changes at 30, and finding the supplement market falling short on clinical credibility, became the founding brief.
Thussheeta Singh is a New Zealand-qualified pharmacist with over a decade in clinical practice. Her formulation standard is simple: every ingredient at the dose used in supporting clinical research, or it does not go in. She oversees all formulation decisions at Maison Belasi, and her pharmacist credential underpins every claim the brand makes.
"I formulated this because no product existed that combined these ingredients at efficacious doses. Most products got the ingredient list right. None of them got the doses right."
Thussheeta Singh · B.Pharm (NZ)
Eight principles.
No exceptions.
Be the first to know.
Join the waitlist for launch updates, early access, and formulation notes from Thussheeta.
Join the waitlist